SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-07-177084
Filing Date
2007-08-09
Accepted
2007-08-09 13:16:59
Documents
10
Period of Report
2007-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 633785
2 LETTER AMENDMENT TO LICENSE AGREEMENT dex102.htm EX-10.2 10318
3 FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT dex103.htm EX-10.3 57405
4 AMENDED & RESTATED 2005 EQUITY COMPENSATION PLAN dex104.htm EX-10.4 71290
5 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9290
6 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9289
7 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3600
8 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3669
9 GRAPHIC g63198image001.jpg GRAPHIC 16678
10 GRAPHIC g63198image002.jpg GRAPHIC 18224
  Complete submission text file 0001193125-07-177084.txt   848456
Mailing Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466
Business Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466 9199419777
INSPIRE PHARMACEUTICALS INC (Filer) CIK: 0001040416 (see all company filings)

IRS No.: 043209022 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31577 | Film No.: 071039051
SIC: 2834 Pharmaceutical Preparations